Molecular targets for selective killing of TRAIL-resistant leukemic cells

Author： Zauli Giorgio Bosco Raffaella Secchiero Paola

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.8, 2011-08, pp. : 931-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy Approaches for the Selective Killing of Cancer Cells

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1683-1694

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL: A Sword for Killing Tumors

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3309-3317

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists

Current Molecular Pharmacology, Vol. 11, Iss. 2, 2018-04 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite

The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6714-6722

Bentham Science Publishers

Access to resources Recommend Favorite

Killing Time for Cancer Stem Cells (CSC): Discovery and Development of Selective CSC Inhibitors

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1719-1725

Bentham Science Publishers

Access to resources Recommend Favorite